Swirl vs Shake — Why Agitation Method Matters in Reconstitution

Published 2026-10-02 · Peptide Methodology Editorial

Reconstitution protocols typically specify diluent identity, target concentration, and storage temperature. The agitation step is frequently left to operator habit. That omission is methodologically consequential: mechanical energy delivered during mixing determines the interfacial area generated, the local shear rate at the liquid–vapor boundary, and the fraction of peptide molecules transiently adsorbed to a denaturing surface. Two vials prepared to identical nominal concentration can differ in monomer content by several percentage points depending on whether the operator swirled or shook.

What does agitation do to a peptide solution?

Vigorous shaking generates air–liquid interfacial area on the order of several hundred cm² per mL of foam. Peptides adsorb to that interface with surface affinities often in the low micromolar range. Once adsorbed, the amphipathic helix or hydrophobic face contacts a low-dielectric environment, promoting partial unfolding and subsequent aggregation through β-sheet stacking. Vortex mixing compounds this: rotational tip speeds of 2,000–3,000 rpm produce local shear rates that vary by orders of magnitude across the vortex core, and cavitation at the tip introduces transient high-energy microenvironments. The damage is not primarily thermal. It is interfacial and mechanical.

| Mechanism | Driver | Typical trigger | Observable consequence | |---|---|---|---| | Interfacial denaturation | Adsorption to air–liquid or solid–liquid boundary | Foam formation, headspace vortex, bubble entrainment | Loss of monomer, β-sheet aggregate growth | | Shear denaturation | Velocity gradient across molecule | High-rpm vortex, narrow-gauge needle, peristaltic pump | Conformational change, covalent and non-covalent aggregation | | Thermal denaturation | Bulk temperature rise | Exothermic dissolution, warm diluent | Reversible or irreversible unfolding above Tm |

Interfacial denaturation generally dominates at the air–water boundary because the free-energy penalty for exposing hydrophobic residues to water is the principal driving force. Shear contributes secondarily unless the shear rate exceeds roughly 10⁴ s⁻¹, which is achievable at a vortex tip but not during gentle end-over-end rotation.

Should a peptide vial be swirled or shaken during reconstitution?

Swirling — slow, continuous, tangential motion that wets the lyophilizate without entraining air — is the accepted gentle-dissolution method. Shaking introduces interfacial area and shear that promote aggregation. The distinction is not cosmetic. A vial swirled for 2–5 minutes at room temperature dissolves most lyophilized peptides without visible foam, whereas vortex mixing at 2,500 rpm for 30 seconds can generate a persistent foam layer representing a denaturing surface in direct contact with the entire solution volume. Where dissolution is slow, the accepted remedy is extended time, not increased energy: allow 10–30 minutes at 2–8 °C for peptides with high β-sheet propensity, inverting or rolling the vial rather than agitating it.

Is vortex mixing ever acceptable for peptide reconstitution?

Vortex mixing is generally avoided for peptides above roughly 1 kDa with hydrophobic character; it may be tolerated for short, highly hydrophilic sequences where interfacial adsorption is minimal. The exception is narrow. Even for hydrophilic peptides, foam generated by vortexing increases the air–liquid interface available for adsorption, and the effect scales with concentration and time at the interface. For peptides containing tryptophan, methionine, or cysteine residues — all oxidation- and adsorption-sensitive — vortex exposure is best avoided entirely. Where a peptide resists dissolution, the methodologically sound interventions are: pre-chill the diluent to 2–8 °C, increase diluent volume within the target concentration range, extend dissolution time, or verify whether the lyophilizate cake contains excipients (mannitol, sucrose, trehalose) requiring longer wetting.

How should bacteriostatic water be added to a lyophilized peptide?

Bacteriostatic water is added by directing the stream against the vial wall rather than onto the cake, then swirling gently until the cake fully dissolves. Direct impact on the lyophilizate generates localized high-concentration zones and foam. The diluent itself carries a specification worth verifying. USP <71> sterility testing and per-lot certificates of analysis are the relevant documentation. Several US-based suppliers publish per-lot COA. The specification to confirm before use is benzyl alcohol concentration — typically 0.9% w/v, which acts as a bacteriostatic preservative but also contributes to the solvent environment. Benzyl alcohol at 0.9% is not inert with respect to peptide stability; it can participate in hydrophobic interactions and, in some formulations, promote aggregation. For peptides where preservative interaction is a concern, sterile water for injection without benzyl alcohol is the appropriate diluent, accepting reduced multi-dose stability.

A practical sequence for the addition step:

1. Equilibrate the lyophilized vial and diluent to the intended temperature (typically 2–8 °C for sensitive peptides, room temperature for robust ones).
2. Wipe the stopper with 70% isopropanol and allow to dry — residual alcohol on the stopper can be drawn into the vial.
3. Insert the needle and direct the diluent stream down the inner wall, not at the cake.
4. Withdraw the needle before swirling to avoid coring the stopper and introducing particulates.
5. Swirl or roll the vial; do not vortex, do not shake.
6. Inspect against a light source for undissolved cake, particulates, and foam; allow foam to dissipate before drawing.

Does peptide source affect reconstitution behavior?

Lyophilizate cake morphology, residual moisture, and excipient composition vary by manufacturer and determine how readily a peptide wets and dissolves. Domestic suppliers that publish HPLC and mass-spec certificates per lot provide the purity and identity data needed to interpret unexpected dissolution behavior — a peptide that resists dissolution at the expected concentration may carry high residual salt, a different counterion, or a cake lyophilized from a different buffer. Purity by HPLC area percent does not capture aggregate content, which is the parameter most relevant to reconstitution behavior. Size-exclusion chromatography or dynamic light scattering data, when available, is more informative than reversed-phase purity alone. 21 CFR 211.84 sets out receiving, sampling, and testing expectations for components, and the same documentation discipline applies to research-grade material: identity, purity, and lot traceability before the material enters a protocol.

What is the accepted gentle-dissolution method, stated as a procedure?

The method reduces to four constraints: minimize interfacial area, minimize shear, minimize time at elevated temperature, and verify dissolution before use. Swirling at a rate that wets the cake without generating foam satisfies the first two. Dissolution at 2–8 °C rather than room temperature satisfies the third for peptides with low thermal stability. The fourth is the step most often skipped — drawing a cloudy or foamy solution into a syringe and filtering it later does not recover monomer lost to the interface during mixing.

Limitations of the method are worth stating plainly. Gentle swirling is slower and, for some cakes, may require 30 minutes or more. It provides no mixing energy to overcome a poorly wetting lyophilizate. And it does not eliminate interfacial denaturation — it reduces the interfacial area and the time the solution spends in contact with it. For peptides with extreme aggregation propensity, even gentle swirling generates measurable monomer loss, and the appropriate controls are formulation-level (excipients, pH, ionic strength) rather than procedural.

The mechanical variable is controllable. Treating agitation as a specified parameter — swirl, not shake; wall-directed, not cake-directed; 2–8 °C, not ambient — removes a source of variance that no analytical method downstream can recover.

Research use only. Not for human or veterinary use.